Skip to main content

Methocarbamol

NDC 72865-234 · XLCare Pharmaceuticals Inc.

Generic nameMethocarbamol
Dosage formTABLET
RouteORAL
Active ingredient(s)METHOCARBAMOL
Strength750 mg/1
Pharmacologic classCentrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
Marketing categoryANDA

Packages

72865-234-01 — 100 TABLET in 1 BOTTLE (72865-234-01)

72865-234-05 — 500 TABLET in 1 BOTTLE (72865-234-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

72789-041 — Methocarbamol, 72789-110 — Methocarbamol, 72789-397 — methocarbamol, 72789-398 — methocarbamol, 72789-428 — methocarbamol, 72789-429 — methocarbamol, 72789-481 — Methocarbamol, 72789-499 — Methocarbamol, 72789-521 — Methocarbamol, 72865-233 — Methocarbamol, 72887-873 — methocarbamol, 73352-510 — Methocarbamol, 76385-123 — Methocarbamol, 76385-124 — Methocarbamol, 76420-040 — Methocarbamol, 76420-258 — methocarbamol, 76420-626 — methocarbamol, 76420-638 — methocarbamol, 76420-667 — methocarbamol, 76420-893 — Methocarbamol Tablets, +188 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels